Alice Ford is a Neurology physician affiliated with University of Pennsylvania. OpenAlex indexes 15 publications with 1,703 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce Street
2 Ravdin
Philadelphia, PA 191044206
Telephone
215-662-3606Provider last certified this registry record 10 Nov 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Philips Electronics North America CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
86.1%Other antiepileptics40.5%Levetiracetam100%Part D<11 patientsMood Stabilizer27.8%Lamotrigine100%Part D<11 patients+ 1 more class in this area
Cardiovascular
13.9%Statin13.9%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2014–2016 per NIH RePORTER. The latest:
- Mechanisms and modifiers of hnRNPA1 and hnRNPA2 misfolding and toxicity
University of Pennsylvania
FY2016$29,869F31NS087676 - Mechanisms and modifiers of hnRNPA1 and hnRNPA2 misfolding and toxicity
University of Pennsylvania
FY2014$46,811F31NS087676
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Vessel wall imaging in the diagnosis of antiphospholipid syndrome presenting as Moyamoya syndrome—A case report
The Neuroradiology Journal
2024 - Heterozygous frameshift variants in HNRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy
Nature Communications
2022 - Reliability of Past Medical History in a Single Hospital Participating in Get With The Guidelines‐Stroke Registry
Journal of the American Heart Association
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Harold Feldman, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”